Clinical Trial Update: Chemotherapy Combined With Apatinib and PD-1 Antibody [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapy combined with apatinib and a PD-1 antibody for gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED